儿童炎症性肠病诊断和治疗专家共识

2019-07-25 中华医学会儿科学分会消化学组 中华儿科杂志.2019,57(7):501-507.

近年来,我国儿童炎症性肠病(IBD)发病率显著升高。国内及国际对儿童IBD诊治的研究进展很快,IBD的诊治水平有了很大提高。中华医学会儿科学分会消化学组和临床营养学组专家借鉴国外最新共识以及国内儿童IBD的临床研究和实践,在更新完善2010年儿童IBD诊断规范共识意见上增加治疗内容,形成新的诊治共识,为IBD患儿的临床管理提供指导意见。

中文标题:

儿童炎症性肠病诊断和治疗专家共识

发布日期:

2019-07-25

简要介绍:

近年来,我国儿童炎症性肠病(IBD)发病率显著升高。国内及国际对儿童IBD诊治的研究进展很快,IBD的诊治水平有了很大提高。中华医学会儿科学分会消化学组和临床营养学组专家借鉴国外最新共识以及国内儿童IBD的临床研究和实践,在更新完善2010年儿童IBD诊断规范共识意见上增加治疗内容,形成新的诊治共识,为IBD患儿的临床管理提供指导意见。

拓展指南:炎症性肠病相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008689, encodeId=49e51008689d9, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:59 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954645, encodeId=c898954645b6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953954, encodeId=dfb29539547b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:56 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953953, encodeId=f079953953f5, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:48 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951024, encodeId=d86c951024ff, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22075450427, createdName=ms2000001530004019, createdTime=Thu Mar 25 14:05:07 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-08-17 DR.Fu SIR

    继续学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008689, encodeId=49e51008689d9, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:59 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954645, encodeId=c898954645b6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953954, encodeId=dfb29539547b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:56 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953953, encodeId=f079953953f5, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:48 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951024, encodeId=d86c951024ff, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22075450427, createdName=ms2000001530004019, createdTime=Thu Mar 25 14:05:07 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008689, encodeId=49e51008689d9, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:59 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954645, encodeId=c898954645b6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953954, encodeId=dfb29539547b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:56 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953953, encodeId=f079953953f5, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:48 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951024, encodeId=d86c951024ff, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22075450427, createdName=ms2000001530004019, createdTime=Thu Mar 25 14:05:07 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-04-05 1255f35dm14暂无昵称

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1008689, encodeId=49e51008689d9, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:59 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954645, encodeId=c898954645b6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953954, encodeId=dfb29539547b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:56 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953953, encodeId=f079953953f5, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:48 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951024, encodeId=d86c951024ff, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22075450427, createdName=ms2000001530004019, createdTime=Thu Mar 25 14:05:07 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-04-05 1255f35dm14暂无昵称

    积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1008689, encodeId=49e51008689d9, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 14:00:59 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954645, encodeId=c898954645b6, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:25:10 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953954, encodeId=dfb29539547b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:56 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953953, encodeId=f079953953f5, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/09/38291cc9e4550a818579d89e34e7841d.jpg, createdBy=6b522560510, createdName=1255f35dm14暂无昵称, createdTime=Mon Apr 05 15:26:48 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951024, encodeId=d86c951024ff, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22075450427, createdName=ms2000001530004019, createdTime=Thu Mar 25 14:05:07 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-03-25 ms2000001530004019

    学习

    0